ONCAlert | Upfront Therapy for mRCC
Targeted Therapies introduces Investigator Perspectives, a video editorial series featuring thought leaders who provide expert perspectives on the latest advances in cancer care.
Select a Topic: – Select a topic –
Breast Cancer
Chronic Lymphocytic Leukemia
Colorectal Cancer
General Cancer
Kidney Cancer
Lung Cancer
Multiple Myeloma
Ovarian Cancer
Prostate Cancer
Skin Cancer
Browse by Series: – Select a Series –
Treatment Options for Stage III Unresectable NSCLC After Chemoradiotherapy
New Immunotherapeutic Agents Broaden Treatment Options for Chronic Lymphocytic Leukemia
PI3K Inhibitors in R/R Follicular Lymphoma
Treatment Options for Recurrent Metastatic Triple-Negative Breast Cancer
SIRT for Nonresectable CRC With Liver Metastases
Systemic Treatment of Metastatic Cutaneous Squamous Cell Carcinoma
Evolving NSCLC Treatment Paradigm
Upfront Therapy for mRCC
NKTR-214 & Nivolumab: Synergistic Activity Across Tumor Types
Endocrine Therapy for HR+ Metastatic Breast Cancer
PARP Inhibitors in Ovarian Cancer
Changing Treatment Landscape in Nonmetastatic CRPC
Immunotherapy in Unresectable Locally Advanced NSCLC
Treatment of Newly Diagnosed Advanced Kidney Cancer
Immunotherapy Use in Newly Diagnosed NSCLC
IMiD Sequencing in Multiple Myeloma